"It is too early to fully assess the therapy's effectiveness and is expensive and time-consuming."
"The idea of the therapy is to boost levels of these cancer-spotting T-cells. It has to be tailored to each patient as each tumour is unique."
Just the above 2 points makes it inferior to CF33 which attacks all cancer and not time-consuming. I don't know if it is going to be expensive or not yet although by all account, it will certainly be far cheaper than anything that needs tailoring to individual patients.
Still the fact that it again relies on waking up the patients own immune system is another confirmation that IMU's is on the right track from the word go with its B-cell and now CF33 platforms.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-7443
-
- There are more pages in this discussion • 7,457 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $404.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17059 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 1772721 | 0.055 |
27 | 2859408 | 0.054 |
19 | 3200959 | 0.053 |
20 | 1760514 | 0.052 |
19 | 1503914 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 748340 | 8 |
0.057 | 1671683 | 14 |
0.058 | 277000 | 6 |
0.059 | 487000 | 5 |
0.060 | 883780 | 13 |
Last trade - 09.53am 29/07/2024 (20 minute delay) ? |
Featured News
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
IMU (ASX) Chart |
Day chart unavailable